A Results from Zafirlukast (ACCOLATE) 9188IL/0124 clinical trial.
Study identifier:9188IL/0124
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Official Title
A Randomized, Double-Blind, Parallel-group Trial to Compare the Safety and Effectiveness of Zafirlukast (ACCOLATE) vs Loratadine vs Placebo in Subjects with Seasonal Allergic Rhinitis: A Day-in-the-Park-Trial.
Medical condition
-
Phase
-
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
-
Age
-
Date
Study Start Date: -
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2022 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
Sort by status
- All Statuses
- Recruiting
- Not yet recruiting
- Recruiting complete
- Completed
- Withdrawn
- Other
No locations available
| Arms | Assigned Interventions |
|---|
